Strengthening US-Mexico Quality Pharmaceutical Supply Chains
Jerry Haar
Professor and Executive Director, The Americas, Florida International University - College of Business
June 11, 2024
Andrew Rudman and Jerry Haar
The US and Mexican governments should provide appropriate incentives and streamlined procedures to capitalize on existing manufacturing capability and know-how to increase North American production. Recognizing the substantial investment required to build a new facility and the lengthy timeline from the first shovel in the ground to the initiation of commercial production, governments should consider tax benefits, guaranteed purchasing contracts at economically feasible prices, streamlined approval and inspection processes for the construction and oversight of completed facilities, and other assistance.? The objective is not to reduce the safety of medications but to ensure that oversight is conducted as efficiently as possible to incentivize investment.